Lipigon Pharmaceuticals
0.00 SEK
-13.79 %
Less than 1K followers
LPGO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Lipigon Pharmaceuticals
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.3 | 10.3 | ||||||
| EBITDA | -6.7 | -11.1 | -25.5 | -9.1 | -8.5 | -7.4 | -7.2 | -32.1 |
| EBIT | -6.7 | -11.1 | -25.6 | -9.1 | -8.5 | -7.4 | -7.2 | -32.2 |
| EBIT-% | -840.2 % | -248.6 % | ||||||
| Profit before taxes | -6.7 | -10.7 | -25.3 | -9.2 | -8.7 | -7.4 | -7.2 | -32.4 |
| Net income | -6.7 | -10.7 | -25.3 | -9.2 | -8.7 | -7.4 | -7.2 | -32.4 |